Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 214

1.

Direct Measurements of Carrier Transport in Polycrystalline Methylammonium Lead Iodide Perovskite Films with Transient Grating Spectroscopy.

Arias DH, Moore DT, van de Lagemaat J, Johnson JC.

J Phys Chem Lett. 2018 Oct 4;9(19):5710-5717. doi: 10.1021/acs.jpclett.8b02245. Epub 2018 Sep 18.

PMID:
30204448
2.

Multicenter, randomized, double-blind phase 2 trial of FOLFIRI with regorafenib or placebo as second-line therapy for metastatic colorectal cancer.

Sanoff HK, Goldberg RM, Ivanova A, O'Reilly S, Kasbari SS, Kim RD, McDermott R, Moore DT, Zamboni W, Grogan W, Cohn AL, Bekaii-Saab TS, Leonard G, Ryan T, Olowokure OO, Fernando NH, McCaffrey J, El-Rayes BF, Horgan AM, Sherrill GB, Yacoub GH, O'Neil BH.

Cancer. 2018 Aug 1;124(15):3118-3126. doi: 10.1002/cncr.31552. Epub 2018 Jun 15.

PMID:
29905927
3.

Interpathologist Diagnostic Agreement for Non-Small Cell Lung Carcinomas Using Current and Recent Classifications.

Funkhouser WK Jr, Hayes DN, Moore DT, Funkhouser WK 3rd, Fine JP, Jo H, Nikolaishvilli-Feinberg N, Eeva M, Grilley-Olson JE, Banks PM, Graziano P, Boswell EL, Elmberger G, Raparia K, Hart CF, Sholl LM, Nolan NJ, Fritchie KJ, Pouagare E, Allen TC, Volmar KE, Biddinger PW, Kleven DT, Papez MJ, Spencer DV, Rekhtman N, Mino-Kenudson M, Hariri L, Driver B, Cagle PT.

Arch Pathol Lab Med. 2018 Apr 30. doi: 10.5858/arpa.2017-0481-OA. [Epub ahead of print]

PMID:
29708428
4.

Peptide Vaccine Formulation Controls the Duration of Antigen Presentation and Magnitude of Tumor-Specific CD8+ T Cell Response.

Khong H, Volmari A, Sharma M, Dai Z, Imo CS, Hailemichael Y, Singh M, Moore DT, Xiao Z, Huang XF, Horvath TD, Hawke DH, Overwijk WW.

J Immunol. 2018 May 15;200(10):3464-3474. doi: 10.4049/jimmunol.1700467. Epub 2018 Apr 11.

PMID:
29643190
5.

Phase Ib Study of Bavituximab With Carboplatin and Pemetrexed in Chemotherapy-Naive Advanced Nonsquamous Non-Small-Cell Lung Cancer.

Grilley-Olson JE, Weiss J, Ivanova A, Villaruz LC, Moore DT, Stinchcombe TE, Lee C, Shan JS, Socinski MA.

Clin Lung Cancer. 2018 Jul;19(4):e481-e487. doi: 10.1016/j.cllc.2018.03.008. Epub 2018 Mar 17.

PMID:
29631965
6.

Switchable photovoltaic windows enabled by reversible photothermal complex dissociation from methylammonium lead iodide.

Wheeler LM, Moore DT, Ihly R, Stanton NJ, Miller EM, Tenent RC, Blackburn JL, Neale NR.

Nat Commun. 2017 Nov 23;8(1):1722. doi: 10.1038/s41467-017-01842-4.

7.

A Phase I Trial of the PI3K Inhibitor Buparlisib Combined With Capecitabine in Patients With Metastatic Breast Cancer.

McRee AJ, Marcom PK, Moore DT, Zamboni WC, Kornblum ZA, Hu Z, Phipps R, Anders CK, Reeder-Hayes K, Carey LA, Weck KE, Perou CM, Dees EC.

Clin Breast Cancer. 2018 Aug;18(4):289-297. doi: 10.1016/j.clbc.2017.10.014. Epub 2017 Oct 28.

PMID:
29153866
8.

Delirium tremens and alcohol withdrawal nationally in the Veterans Health Administration.

Moore DT, Fuehrlein BS, Rosenheck RA.

Am J Addict. 2017 Oct;26(7):722-730. doi: 10.1111/ajad.12603. Epub 2017 Aug 24.

PMID:
28836711
9.

A Focused Addiction Curriculum and Its Impact on Student Knowledge, Attitudes, and Confidence in the Treatment of Patients with Substance Use.

Feeley RJ, Moore DT, Wilkins K, Fuehrlein B.

Acad Psychiatry. 2018 Apr;42(2):304-308. doi: 10.1007/s40596-017-0771-8. Epub 2017 Aug 3.

PMID:
28776146
10.

Final Results of a Phase 1 Study of Vorinostat, Pegylated Liposomal Doxorubicin, and Bortezomib in Relapsed or Refractory Multiple Myeloma.

Voorhees PM, Gasparetto C, Moore DT, Winans D, Orlowski RZ, Hurd DD.

Clin Lymphoma Myeloma Leuk. 2017 Jul;17(7):424-432. doi: 10.1016/j.clml.2017.05.007. Epub 2017 May 10.

PMID:
28655599
11.

Synthesis and Spectroscopy of Silver-Doped PbSe Quantum Dots.

Kroupa DM, Hughes BK, Miller EM, Moore DT, Anderson NC, Chernomordik BD, Nozik AJ, Beard MC.

J Am Chem Soc. 2017 Aug 2;139(30):10382-10394. doi: 10.1021/jacs.7b04551. Epub 2017 Jul 24.

PMID:
28648060
12.

Comprehensive services delivery and emergency department use among chronically homeless adults.

Moore DT, Rosenheck RA.

Psychol Serv. 2017 May;14(2):184-192. doi: 10.1037/ser0000111.

13.

Prior breast cancer and tamoxifen exposure does not influence outcomes in women with uterine papillary serous carcinoma.

Pierce SR, Stine JE, Gehrig PA, Havrilesky LJ, Secord AA, Nakayama J, Snavely AC, Moore DT, Kim KH.

Gynecol Oncol. 2017 Mar;144(3):531-535. doi: 10.1016/j.ygyno.2016.12.024. Epub 2017 Jan 3.

PMID:
28062116
14.

Cancer Risk after Fat Transfer: A Multicenter Case-Cohort Study.

Myckatyn TM, Wagner IJ, Mehrara BJ, Crosby MA, Park JE, Qaqish BF, Moore DT, Busch EL, Silva AK, Kaur S, Ollila DW, Lee CN.

Plast Reconstr Surg. 2017 Jan;139(1):11-18. doi: 10.1097/PRS.0000000000002838.

15.

Quantum dot-induced phase stabilization of α-CsPbI3 perovskite for high-efficiency photovoltaics.

Swarnkar A, Marshall AR, Sanehira EM, Chernomordik BD, Moore DT, Christians JA, Chakrabarti T, Luther JM.

Science. 2016 Oct 7;354(6308):92-95.

PMID:
27846497
16.

Mechanism for rapid growth of organic-inorganic halide perovskite crystals.

Nayak PK, Moore DT, Wenger B, Nayak S, Haghighirad AA, Fineberg A, Noel NK, Reid OG, Rumbles G, Kukura P, Vincent KA, Snaith HJ.

Nat Commun. 2016 Nov 10;7:13303. doi: 10.1038/ncomms13303.

17.

Simultaneous interferometric measurement of linear coefficient of thermal expansion and temperature-dependent refractive index coefficient of optical materials.

Corsetti JA, Green WE, Ellis JD, Schmidt GR, Moore DT.

Appl Opt. 2016 Oct 10;55(29):8145-8152. doi: 10.1364/AO.55.008145.

PMID:
27828056
18.

Analysis of Pre-existing IgG and IgM Antibodies against Polyethylene Glycol (PEG) in the General Population.

Yang Q, Jacobs TM, McCallen JD, Moore DT, Huckaby JT, Edelstein JN, Lai SK.

Anal Chem. 2016 Dec 6;88(23):11804-11812. Epub 2016 Nov 16.

PMID:
27804292
19.

Factors Affecting Emergency Department Use by a Chronically Homeless Population.

Moore DT, Rosenheck RA.

Psychiatr Serv. 2016 Dec 1;67(12):1340-1347. Epub 2016 Jul 15.

20.

Directly Activating the Integrin αIIbβ3 Initiates Outside-In Signaling by Causing αIIbβ3 Clustering.

Fong KP, Zhu H, Span LM, Moore DT, Yoon K, Tamura R, Yin H, DeGrado WF, Bennett JS.

J Biol Chem. 2016 May 27;291(22):11706-16. doi: 10.1074/jbc.M116.716613. Epub 2016 Apr 7.

21.

Endometrial Cancer Survivors' Perceptions of Provider Obesity Counseling and Attempted Behavior Change: Are We Seizing the Moment?

Clark LH, Ko EM, Kernodle A, Harris A, Moore DT, Gehrig PA, Bae-Jump V.

Int J Gynecol Cancer. 2016 Feb;26(2):318-24. doi: 10.1097/IGC.0000000000000596.

PMID:
26588234
22.

Absolute thickness metrology with submicrometer accuracy using a low-coherence distance measuring interferometer.

Zhao Y, Schmidt G, Moore DT, Ellis JD.

Appl Opt. 2015 Sep 1;54(25):7693-700. doi: 10.1364/AO.54.007693.

PMID:
26368894
23.

Chemical Reactions Triggered Using Electrons Photodetached from "Clean" Distributions of Anions Deposited in Cryogenic Matrices via Counterion Codeposition.

Ludwig RM, Moore DT.

J Phys Chem Lett. 2014 Sep 4;5(17):2947-50. doi: 10.1021/jz501547b. Epub 2014 Aug 19.

PMID:
26278241
24.

The Tyrosine Kinase c-Src Specifically Binds to the Active Integrin αIIbβ3 to Initiate Outside-in Signaling in Platelets.

Wu Y, Span LM, Nygren P, Zhu H, Moore DT, Cheng H, Roder H, DeGrado WF, Bennett JS.

J Biol Chem. 2015 Jun 19;290(25):15825-34. doi: 10.1074/jbc.M115.648428. Epub 2015 May 6.

25.

Obesity and perioperative pulmonary complications in robotic gynecologic surgery.

Wysham WZ, Kim KH, Roberts JM, Sullivan SA, Campbell SB, Roque DR, Moore DT, Gehrig PA, Boggess JF, Soper JT, Huh WK.

Am J Obstet Gynecol. 2015 Jul;213(1):33.e1-33.e7. doi: 10.1016/j.ajog.2015.01.033. Epub 2015 Jan 28.

PMID:
25637843
26.

Ultrasmooth organic-inorganic perovskite thin-film formation and crystallization for efficient planar heterojunction solar cells.

Zhang W, Saliba M, Moore DT, Pathak SK, Hörantner MT, Stergiopoulos T, Stranks SD, Eperon GE, Alexander-Webber JA, Abate A, Sadhanala A, Yao S, Chen Y, Friend RH, Estroff LA, Wiesner U, Snaith HJ.

Nat Commun. 2015 Jan 30;6:6142. doi: 10.1038/ncomms7142.

PMID:
25635571
27.

Crystallization kinetics of organic-inorganic trihalide perovskites and the role of the lead anion in crystal growth.

Moore DT, Sai H, Tan KW, Smilgies DM, Zhang W, Snaith HJ, Wiesner U, Estroff LA.

J Am Chem Soc. 2015 Feb 18;137(6):2350-8. doi: 10.1021/ja512117e. Epub 2015 Feb 9.

PMID:
25625616
28.

A randomized phase II study of carboplatin with weekly or every-3-week nanoparticle albumin-bound paclitaxel (abraxane) in patients with extensive-stage small cell lung cancer.

Grilley-Olson JE, Keedy VL, Sandler A, Moore DT, Socinski MA, Stinchcombe TE.

Oncologist. 2015 Feb;20(2):105-6. doi: 10.1634/theoncologist.2014-0327. Epub 2015 Jan 23.

29.

The fidelity of the ligation step determines how ends are resolved during nonhomologous end joining.

Waters CA, Strande NT, Pryor JM, Strom CN, Mieczkowski P, Burkhalter MD, Oh S, Qaqish BF, Moore DT, Hendrickson EA, Ramsden DA.

Nat Commun. 2014 Jul 3;5:4286. doi: 10.1038/ncomms5286.

30.

Thermally induced structural evolution and performance of mesoporous block copolymer-directed alumina perovskite solar cells.

Tan KW, Moore DT, Saliba M, Sai H, Estroff LA, Hanrath T, Snaith HJ, Wiesner U.

ACS Nano. 2014 May 27;8(5):4730-9. doi: 10.1021/nn500526t. Epub 2014 Apr 11.

31.

The complex triad of obesity, diabetes and race in Type I and II endometrial cancers: prevalence and prognostic significance.

Ko EM, Walter P, Clark L, Jackson A, Franasiak J, Bolac C, Havrilesky L, Secord AA, Moore DT, Gehrig PA, Bae-Jump VL.

Gynecol Oncol. 2014 Apr;133(1):28-32. doi: 10.1016/j.ygyno.2014.01.032.

PMID:
24680588
32.

Supercapacitive swing adsorption of carbon dioxide.

Kokoszka B, Jarrah NK, Liu C, Moore DT, Landskron K.

Angew Chem Int Ed Engl. 2014 Apr 1;53(14):3698-701. doi: 10.1002/anie.201310308. Epub 2014 Feb 24.

PMID:
24616112
33.

Impact of comorbidity on health-related quality of life after prostate cancer treatment: combined analysis of two prospective cohort studies.

Reeve BB, Chen RC, Moore DT, Deal AM, Usinger DS, Lyons JC, Talcott JA.

BJU Int. 2014 Dec;114(6b):E74-E81. doi: 10.1111/bju.12723. Epub 2014 Aug 16.

34.

Effect of drug release kinetics on nanoparticle therapeutic efficacy and toxicity.

Sethi M, Sukumar R, Karve S, Werner ME, Wang EC, Moore DT, Kowalczyk SR, Zhang L, Wang AZ.

Nanoscale. 2014 Feb 21;6(4):2321-2327. doi: 10.1039/c3nr05961h. Epub 2014 Jan 14.

35.

Formation of ionic complexes in cryogenic matrices: a case study using co-deposition of Cu- with rare gas cations in solid argon.

Ludwig RM, Moore DT.

J Chem Phys. 2013 Dec 28;139(24):244202. doi: 10.1063/1.4851335.

PMID:
24387363
36.

Metformin is associated with improved survival in endometrial cancer.

Ko EM, Walter P, Jackson A, Clark L, Franasiak J, Bolac C, Havrilesky LJ, Secord AA, Moore DT, Gehrig PA, Bae-Jump V.

Gynecol Oncol. 2014 Feb;132(2):438-42. doi: 10.1016/j.ygyno.2013.11.021. Epub 2013 Nov 22.

PMID:
24269517
37.

The volumetric response of brain metastases after stereotactic radiosurgery and its post-treatment implications.

Sharpton SR, Oermann EK, Moore DT, Schreiber E, Hoffman R, Morris DE, Ewend MG.

Neurosurgery. 2014 Jan;74(1):9-15; discussion 16; quiz 16. doi: 10.1227/NEU.0000000000000190.

PMID:
24077581
38.

Preclinical evaluation of Genexol-PM, a nanoparticle formulation of paclitaxel, as a novel radiosensitizer for the treatment of non-small cell lung cancer.

Werner ME, Cummings ND, Sethi M, Wang EC, Sukumar R, Moore DT, Wang AZ.

Int J Radiat Oncol Biol Phys. 2013 Jul 1;86(3):463-468. doi: 10.1016/j.ijrobp.2013.02.009.

39.

Outpatient end of life discussions shorten hospital admissions in gynecologic oncology patients.

Doll KM, Stine JE, Van Le L, Moore DT, Bae-Jump V, Brewster WR, Soper JT, Boggess JF, Gehrig PA, Kim KH.

Gynecol Oncol. 2013 Jul;130(1):152-5. doi: 10.1016/j.ygyno.2013.03.020. Epub 2013 Mar 29.

PMID:
23542684
40.

A retrospective analysis of VeriStrat status on outcome of a randomized phase II trial of first-line therapy with gemcitabine, erlotinib, or the combination in elderly patients (age 70 years or older) with stage IIIB/IV non-small-cell lung cancer.

Stinchcombe TE, Roder J, Peterman AH, Grigorieva J, Lee CB, Moore DT, Socinski MA.

J Thorac Oncol. 2013 Apr;8(4):443-51. doi: 10.1097/JTO.0b013e3182835577. Erratum in: J Thorac Oncol. 2013 Jun;8(6):814.

41.

Phase 2 study of pre-excision single-dose intraoperative radiation therapy for early-stage breast cancers: six-year update with application of the ASTRO accelerated partial breast irradiation consensus statement criteria.

Vanderwalde NA, Jones EL, Kimple RJ, Moore DT, Klauber-Demore N, Sartor CI, Ollila DW.

Cancer. 2013 May 1;119(9):1736-43. doi: 10.1002/cncr.27915. Epub 2013 Jan 29.

42.

Incorporating bevacizumab and erlotinib in the combined-modality treatment of stage III non-small-cell lung cancer: results of a phase I/II trial.

Socinski MA, Stinchcombe TE, Moore DT, Gettinger SN, Decker RH, Petty WJ, Blackstock AW, Schwartz G, Lankford S, Khandani A, Morris DE.

J Clin Oncol. 2012 Nov 10;30(32):3953-9. doi: 10.1200/JCO.2012.41.9820. Epub 2012 Oct 8.

PMID:
23045594
43.
44.

A multi-institutional cohort study of adjuvant therapy in stage I-II uterine carcinosarcoma.

Cantrell LA, Havrilesky L, Moore DT, O'Malley D, Liotta M, Secord AA, Nagel CI, Cohn DE, Fader AN, Wallace AH, Rose P, Gehrig PA.

Gynecol Oncol. 2012 Oct;127(1):22-6. doi: 10.1016/j.ygyno.2012.06.020. Epub 2012 Jun 20.

PMID:
22727985
45.

Primary renal cell carcinoma: relationship between 18F-FDG uptake and response to neoadjuvant sorafenib.

Khandani AH, Cowey CL, Moore DT, Gohil H, Rathmell WK.

Nucl Med Commun. 2012 Sep;33(9):967-73. doi: 10.1097/MNM.0b013e3283561837.

PMID:
22714005
46.

Efficacy of Saccharomyces cerevisiae fermentation product on intestinal health and productivity of coccidian-challenged laying hens.

Lensing M, van der Klis JD, Yoon I, Moore DT.

Poult Sci. 2012 Jul;91(7):1590-7. doi: 10.3382/ps.2011-01508.

PMID:
22700503
47.

Validation of interobserver agreement in lung cancer assessment: hematoxylin-eosin diagnostic reproducibility for non-small cell lung cancer: the 2004 World Health Organization classification and therapeutically relevant subsets.

Grilley-Olson JE, Hayes DN, Moore DT, Leslie KO, Wilkerson MD, Qaqish BF, Hayward MC, Cabanski CR, Yin X, Socinski MA, Stinchcombe TE, Thorne LB, Allen TC, Banks PM, Beasley MB, Borczuk AC, Cagle PT, Christensen R, Colby TV, Deblois GG, Elmberger G, Graziano P, Hart CF, Jones KD, Maia DM, Miller CR, Nance KV, Travis WD, Funkhouser WK.

Arch Pathol Lab Med. 2013 Jan;137(1):32-40. doi: 10.5858/arpa.2012-0033-OA. Epub 2012 May 14.

48.

Epstein-Barr virus-encoded latent membrane protein 1 (LMP1) and LMP2A function cooperatively to promote carcinoma development in a mouse carcinogenesis model.

Shair KH, Bendt KM, Edwards RH, Nielsen JN, Moore DT, Raab-Traub N.

J Virol. 2012 May;86(9):5352-65. doi: 10.1128/JVI.07035-11. Epub 2012 Feb 22.

49.

The role of polar, lamdba (Λ)-shaped building units in noncentrosymmetric inorganic structures.

Donakowski MD, Gautier R, Yeon J, Moore DT, Nino JC, Halasyamani PS, Poeppelmeier KR.

J Am Chem Soc. 2012 May 9;134(18):7679-89. doi: 10.1021/ja210984k. Epub 2012 Feb 15.

PMID:
22335338
50.

Improved time to progression for transarterial chemoembolization compared with transarterial embolization for patients with unresectable hepatocellular carcinoma.

Morse MA, Hanks BA, Suhocki P, Doan PL, Liu EA, Frost P, Bernard SA, Tsai A, Moore DT, O'Neil BH.

Clin Colorectal Cancer. 2012 Sep;11(3):185-90. doi: 10.1016/j.clcc.2011.11.003. Epub 2012 Jan 26.

PMID:
22280845

Supplemental Content

Loading ...
Support Center